Drug:
Reaction: THERAPY INTERRUPTED
20260101 - 20261231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 26818624 |
US |
29 | 1 |
Eye irritation, Therapy interrupted, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 902 | 26818702 |
US |
18 | 2 |
Therapy interrupted, Product use issue, Withdrawal syndrome, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 903 | 26818815 |
GB |
41 | |
Rheumatoid arthritis, Therapy interrupted, Product use issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 904 | 26819057 |
US |
66 | 1 |
Insurance issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 905 | 26819259 |
US |
81 | 1 |
Neoplasm malignant, Illness, Intentional self-injury, Paralysis, Terminal state, Therapy interrupted, Sciatica, Hypoacusis, Fall, Fatigue, Cardiac disorder, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 906 | 26819293 |
US |
80 | 1 |
Product packaging quantity issue, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 907 | 26819351 |
US |
2 | |
Ankylosing spondylitis, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 908 | 26822465 |
66 | 2 | |
Product use issue, Therapy interrupted, Pulmonary resection, |
||||
TENOFOVIR ALAFENAMIDE, |
||||
| 909 | 26822467 |
1 | ||
Chest pain, Therapy interrupted, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, CYCLOSPORINE, |
||||
| 910 | 26822483 |
67 | 2 | |
Infection, Leg amputation, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 911 | 26822362 |
1 | ||
Therapy interrupted, |
||||
MAVACAMTEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, METHOCARBAMOL, METHOCARBAMOL TABLETS, STANDARDIZED SENNA CONCENTRATE, POLYETHYLENE GLYCOL 3350, LISINOPRIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OXYBUTYNIN, ROPINIROLE, SERTRALINE, |
||||
| 912 | 26822366 |
1 | ||
Therapy interrupted, Palmar-plantar erythrodysaesthesia syndrome, |
||||
AXITINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLOPURINOL, BIOTIN, TADALAFIL, GABAPENTIN, |
||||
| 913 | 26822369 |
13 | 2 | |
Therapy interrupted, Insurance issue, Ocular discomfort, |
||||
ADALIMUMAB, |
||||
| 914 | 26822371 |
79 | 1 | |
Therapy interrupted, Fatigue, |
||||
APALUTAMIDE, |
||||
| 915 | 26824080 |
55 | 2 | |
Loss of consciousness, Blood pressure decreased, Mental disorder, Oedema, Inflammation, Insurance issue, Therapy interrupted, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LOSARTAN, PHENTERMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 916 | 26813446 |
CA |
1 | |
Lower respiratory tract infection, Bone pain, Wheezing, Candida infection, Illness, Respiratory tract infection, Tremor, Pain, Therapy interrupted, Back pain, Pain in extremity, Tooth loss, Osteoporosis, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 917 | 26813999 |
US |
79 | 2 |
Hospitalisation, Blindness, Eye pain, Eye irritation, Product use issue, Therapy interrupted, |
||||
LIFITEGRAST, |
||||
| 918 | 26814446 |
US |
83 | 2 |
Dry age-related macular degeneration, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 919 | 26814974 |
US |
79 | 1 |
Hospitalisation, Inability to afford medication, Therapy interrupted, |
||||
| 920 | 26815073 |
US |
10 | 1 |
Seasonal allergy, Therapy interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, LORATADINE, LORATADINE TABLET, FAMOTIDINE, ALBUTEROL SULFATE, TADALAFIL, IRON, OXYGEN, 0XYGEN, MELATONIN, |
||||
| 921 | 26815323 |
US |
1 | |
Pneumonia, Pulmonary haemorrhage, Haemoptysis, Pulmonary resection, Therapy interrupted, |
||||
BRENSOCATIB, BRENSOCATIB, |
||||
| 922 | 26815335 |
US |
90 | 2 |
Dry mouth, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 923 | 26815756 |
2 | ||
Uterine cyst, Therapy interrupted, |
||||
RIBOCICLIB, |
||||
| 924 | 26815757 |
2 | ||
Therapy interrupted, Uterine cyst, |
||||
RIBOCICLIB, |
||||
| 925 | 26815816 |
2 | ||
Palpitations, Therapy interrupted, |
||||
CAPMATINIB, |
||||
| 926 | 26816067 |
GB |
44 | 1 |
Lower respiratory tract infection, Malaise, Surgery, Inappropriate schedule of product administration, Illness, Decreased immune responsiveness, Therapy interrupted, Infection, Dyspnoea, Ill-defined disorder, Bone pain, |
||||
USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREGABALIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 927 | 26816430 |
|||
Therapy interrupted, Insurance issue, Multiple sclerosis relapse, |
||||
FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, |
||||
| 928 | 26816458 |
US |
72 | 2 |
Rheumatoid arthritis, Dizziness, Product dose omission issue, Intentional product misuse, Incorrect disposal of product, Therapy interrupted, Hypotension, |
||||
ETANERCEPT, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, HYDROXYCHLOROQUINE, |
||||
| 929 | 26816553 |
|||
Constipation, Therapy interrupted, Product use issue, |
||||
UPADACITINIB, |
||||
| 930 | 26816650 |
2 | ||
Nephrolithiasis, Therapy interrupted, |
||||
LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BACLOFEN, CALCIUM, LEVETIRACETAM, LAMOTRIGINE, |
||||
| 931 | 26816745 |
CA |
||
Anxiety, Attention deficit hyperactivity disorder, Drug interaction, Headache, Hepatic pain, Pain, Product availability issue, Product size issue, Rash, Swelling, Tremor, Vaginal disorder, Brain fog, Breast pain, Joint swelling, Peripheral swelling, Photosensitivity reaction, Product dosage form issue, Product taste abnormal, Suspected product tampering, Abdominal pain, Alopecia, Drug ineffective, Dyspepsia, Hyperhidrosis, Gastrointestinal pain, Product formulation issue, Product physical consistency issue, Product substitution issue, Temperature regulation disorder, Therapy interrupted, Withdrawal syndrome, Burning sensation, Condition aggravated, Dyspnoea, Product colour issue, Anorectal disorder, Arthralgia, Chills, Dysphagia, Paraesthesia, Product physical issue, Product shape issue, Cognitive disorder, Haemorrhage, Rash erythematous, Urinary tract pain, |
||||
ESCITALOPRAM OXALATE, ESCITALOPRAM, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, MAGNESIUM, NIRMATRELVIR AND RITONAVIR, FAMOTIDINE, ERGOCALCIFEROL, |
||||
| 932 | 26816751 |
75 | 1 | |
Atrial fibrillation, Therapy interrupted, |
||||
TERIPARATIDE, |
||||
| 933 | 26816754 |
2 | ||
Pneumonia, Sepsis, Blood pressure decreased, Therapy interrupted, |
||||
ETANERCEPT, DENOSUMAB, |
||||
| 934 | 26817146 |
US |
1 | |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 935 | 26817501 |
US |
17 | 2 |
Dry skin, Therapy interrupted, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 936 | 26822115 |
2 | ||
Herpes zoster, Impaired healing, Therapy interrupted, |
||||
APREMILAST, ABATACEPT, |
||||
| 937 | 26823271 |
79 | 1 | |
Therapy interrupted, Confusional state, Aphasia, Body temperature decreased, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 938 | 26823460 |
74 | 1 | |
Therapy interrupted, Blood glucose increased, Diarrhoea, |
||||
TIRZEPATIDE, ERGOCALCIFEROL, METHADONE, HYDROCHLOROTHIAZIDE, AMLODIPINE, IRBESARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, |
||||
| 939 | 26823984 |
51 | 2 | |
Adverse drug reaction, Gastrooesophageal reflux disease, Bone pain, Spinal fracture, Therapy non-responder, Therapy interrupted, |
||||
ERGOCALCIFEROL, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, |
||||
| 940 | 26809042 |
CO |
89 | 1 |
Cerebrovascular accident, Mental disorder, Anxiety, Intentional dose omission, Hyperhidrosis, Pain, Prostatic specific antigen increased, Therapy interrupted, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 941 | 26809222 |
US |
70 | 2 |
Therapy interrupted, Drug ineffective, |
||||
GUSELKUMAB, |
||||
| 942 | 26809391 |
CA |
63 | 2 |
Knee arthroplasty, Breast cancer, Psoriasis, Therapeutic product effect incomplete, Therapy interrupted, |
||||
APREMILAST, APREMILAST, |
||||
| 943 | 26809728 |
US |
1 | 2 |
Drug ineffective, Developmental hip dysplasia, Cast application, Therapy interrupted, |
||||
AMLODIPINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, DOXAZOSIN, DOXAZOSIN MESYLATE, SOMATROPIN, HUMAN IMMUNOGLOBULIN G, |
||||
| 944 | 26809938 |
US |
60 | 1 |
Psoriasis, Nasopharyngitis, Therapy interrupted, |
||||
ETANERCEPT, APREMILAST, |
||||
| 945 | 26810459 |
CA |
59 | |
Abdominal wound dehiscence, Nephrolithiasis, Weight decreased, Calculus urinary, Weight increased, Off label use, Therapy interrupted, Inappropriate schedule of product administration, Suspected off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 946 | 26810530 |
US |
71 | 1 |
Underdose, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, GABAPENTIN, CLOPIDOGREL BISULFATE, MONTELUKAST, BUPROPION HYDROCHLORIDE, ROSUVASTATIN, EMPAGLIFLOZIN, SERTRALINE, |
||||
| 947 | 26811038 |
BR |
79 | 2 |
Crohn^s disease, Thyroid mass, Weight decreased, Cystitis noninfective, Gastrointestinal inflammation, Neck pain, Therapy interrupted, Product availability issue, |
||||
CANDESARTAN CILEXETIL, ESCITALOPRAM OXALATE, ESCITALOPRAM, LORAZEPAM, ROSUVASTATIN CALCIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, EZETIMIBE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 948 | 26811380 |
US |
76 | 2 |
Spinal fracture, Fibromyalgia, Eye pain, Retching, Abdominal discomfort, Nausea, Abdominal pain upper, Pain, Back pain, Palpitations, Therapy interrupted, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 949 | 26811537 |
1 | ||
Therapy interrupted, Skin ulcer, Withdrawal syndrome, |
||||
TOFACITINIB, |
||||
| 950 | 26811544 |
2 | ||
Diabetic complication, Therapy interrupted, |
||||
TADALAFIL, AMBRISENTAN, SOTATERCEPT-CSRK, |
||||
| 951 | 26811603 |
|||
Hospitalisation, Therapy interrupted, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 952 | 26811635 |
2 | ||
Infection, Therapy interrupted, |
||||
LENALIDOMIDE, ACYCLOVIR, AMOXICILLIN, BUMETANIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CARVEDILOL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FERROUS SULFATE, |
||||
| 953 | 26811637 |
71 | 1 | |
Transient ischaemic attack, Therapy interrupted, |
||||
SOTATERCEPT-CSRK, TREPROSTINIL, |
||||
| 954 | 26811639 |
2 | ||
Thrombosis, Therapy interrupted, |
||||
LENALIDOMIDE, ZOLEDRONIC ACID, |
||||
| 955 | 26811824 |
US |
20 | 2 |
Therapy interrupted, |
||||
ISOTRETINOIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 956 | 26812029 |
1 | ||
Therapy interrupted, Product availability issue, |
||||
BACILLUS CALMETTE-GUERIN, |
||||
| 957 | 26812048 |
2 | ||
Product availability issue, Therapy interrupted, Burning sensation, Haemorrhage, Procedural complication, |
||||
BACILLUS CALMETTE-GUERIN, |
||||
| 958 | 26812135 |
2 | ||
Therapy interrupted, |
||||
BACILLUS CALMETTE-GUERIN, CISPLATIN, |
||||
| 959 | 26812258 |
US |
52 | 2 |
Memory impairment, Confusional state, Therapy interrupted, Insurance issue, Inability to afford medication, |
||||
RIFAXIMIN, |
||||
| 960 | 26812298 |
2 | ||
Anaemia, Fatigue, Therapy interrupted, |
||||
BELZUTIFAN, |
||||
| 961 | 26812374 |
71 | 1 | |
Pain, Somnolence, Diarrhoea, Adverse drug reaction, Therapy interrupted, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 962 | 26812378 |
80 | 2 | |
Pneumonia, Therapy interrupted, Joint swelling, Treatment delayed, |
||||
MACITENTAN, |
||||
| 963 | 26812742 |
GB |
32 | 2 |
Drug ineffective, Amenorrhoea, Therapy interrupted, |
||||
| 964 | 26815432 |
|||
Inability to afford medication, Therapy interrupted, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 965 | 26816350 |
2 | ||
Therapy non-responder, Pain, Loss of personal independence in daily activities, Infection, Therapy interrupted, Malaise, Nasopharyngitis, Influenza, |
||||
CERTOLIZUMAB PEGOL, DUPILUMAB, PREDNISONE, |
||||
| 966 | 26816391 |
2 | ||
Infection, Therapy interrupted, |
||||
OMALIZUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CYANOCOBALAMIN, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MELOXICAM, |
||||
| 967 | 26803832 |
CA |
2 | |
Juvenile idiopathic arthritis, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 968 | 26803853 |
US |
2 | |
Headache, Therapy interrupted, Feeling abnormal, |
||||
ERENUMAB-AOOE, |
||||
| 969 | 26803922 |
US |
72 | 2 |
Therapy interrupted, Device malfunction, Product use complaint, Product physical issue, |
||||
ESTRADIOL, |
||||
| 970 | 26803928 |
US |
72 | 2 |
Therapy interrupted, Device malfunction, Product use complaint, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 971 | 26804702 |
US |
80 | 1 |
Therapy interrupted, Treatment noncompliance, |
||||
CARVEDILOL, LOSARTAN POTASSIUM, ATORVASTATIN CALCIUM, PANTOPRAZOLE SODIUM, |
||||
| 972 | 26805143 |
US |
2 | |
Adverse event, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 973 | 26805213 |
US |
2 | |
Psoriatic arthropathy, Psoriasis, Therapy interrupted, |
||||
APREMILAST, APREMILAST, |
||||
| 974 | 26805243 |
US |
2 | |
Hospitalisation, Infection, Platelet count decreased, Therapy interrupted, |
||||
BRENSOCATIB, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, AZELASTINE, RITUXIMAB, |
||||
| 975 | 26805277 |
US |
57 | 2 |
Psoriatic arthropathy, Arthritis, Metabolic dysfunction-associated steatohepatitis, Anaemia, Urinary tract infection, Therapy interrupted, Psoriasis, Headache, Intervertebral disc degeneration, Off label use, Intentional product misuse, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, APREMILAST, APREMILAST, APREMILAST, HYDROXYZINE, LOSARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREGABALIN, ROSUVASTATIN, ORAL SEMAGLUTIDE, |
||||
| 976 | 26805454 |
US |
82 | 1 |
Hot flush, Product dose omission in error, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, LISINOPRIL, VITAMIN E, |
||||
| 977 | 26805460 |
US |
36 | 2 |
Rhupus syndrome, Therapy interrupted, Loss of personal independence in daily activities, Musculoskeletal disorder, Gait inability, Pain, Hypersomnia, Asthenia, Grip strength decreased, Transfusion, Hepatic function abnormal, |
||||
ETANERCEPT, ETANERCEPT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 978 | 26805942 |
US |
||
Product use issue, Insurance issue, Therapy interrupted, Headache, Vomiting, Insomnia, Fatigue, Mania, |
||||
VILOXAZINE HYDROCHLORIDE, |
||||
| 979 | 26806359 |
US |
57 | 1 |
Weight increased, Hepatic enzyme increased, Incorrect dose administered, Therapy interrupted, |
||||
RELUGOLIX, |
||||
| 980 | 26806620 |
US |
1 | |
Rheumatoid arthritis, Injection site bruising, Infection, Therapy interrupted, Rash, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 981 | 26806670 |
63 | 2 | |
Arthralgia, Therapy interrupted, Subdural haematoma, Urinary incontinence, |
||||
ANASTROZOLE, |
||||
| 982 | 26807154 |
2 | ||
Tremor, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 983 | 26807159 |
2 | ||
Product dispensing error, Therapy interrupted, |
||||
BELZUTIFAN, |
||||
| 984 | 26808238 |
2 | ||
Therapy interrupted, Breast cancer, |
||||
UPADACITINIB, |
||||
| 985 | 26808347 |
81 | 1 | |
Pneumonia, Memory impairment, Product use issue, Therapy interrupted, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 986 | 26808500 |
2 | ||
Viral infection, Therapy interrupted, |
||||
AMBRISENTAN, FUROSEMIDE, TADALAFIL, |
||||
| 987 | 26808805 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, Product use in unapproved indication, |
||||
APREMILAST, APREMILAST, |
||||
| 988 | 26810555 |
77 | 2 | |
Therapy interrupted, Fall, Limb injury, |
||||
GOLIMUMAB, |
||||
| 989 | 26811147 |
68 | 1 | |
Therapy interrupted, Hospitalisation, Rehabilitation therapy, Product availability issue, |
||||
AVACOPAN, |
||||
| 990 | 26811262 |
1 | ||
Therapy interrupted, Hospitalisation, |
||||
MAVACAMTEN, CLONAZEPAM, NADOLOL, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 991 | 26811326 |
2 | ||
Therapy interrupted, Thyroidectomy, |
||||
LENALIDOMIDE, |
||||
| 992 | 26811509 |
2 | ||
Therapy interrupted, Therapy non-responder, Loss of personal independence in daily activities, Pain, |
||||
ABATACEPT, |
||||
| 993 | 26811512 |
45 | 2 | |
Pulmonary hypertension, Anaemia, Therapy interrupted, |
||||
MACITENTAN, |
||||
| 994 | 26811513 |
69 | 2 | |
Fatigue, Nausea, Decreased appetite, Therapy interrupted, |
||||
LENALIDOMIDE, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACYCLOVIR, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCHLOROTHIAZIDE, |
||||
| 995 | 26811695 |
2 | ||
Discomfort, Pneumonia, Sepsis, Therapy interrupted, |
||||
BELIMUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYCHLOROQUINE, LOSARTAN POTASSIUM, LOSARTAN, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 996 | 26812301 |
2 | ||
Surgery, Therapy interrupted, |
||||
LORLATINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROMORPHONE HYDROCHLORIDE, GABAPENTIN, LEVETIRACETAM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PANTOPRAZOLE, ROSUVASTATIN, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, |
||||
| 997 | 26812315 |
2 | ||
Foot operation, Therapy interrupted, Condition aggravated, |
||||
TOFACITINIB, |
||||
| 998 | 26812316 |
59 | 2 | |
Jaw operation, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 999 | 26798516 |
US |
2 | |
Spinal operation, Arthropathy, Therapy interrupted, Pain, Back disorder, Pain in extremity, |
||||
APREMILAST, |
||||
| 1000 | 26798645 |
41 | ||
Psoriatic arthropathy, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30